Standard InChI: InChI=1S/C27H41N3O5/c1-6-8-12-18(4)22-16-23(31)29-21(15-20-13-10-9-11-14-20)26(33)28-19(5)25(32)30-24(17(3)7-2)27(34)35-22/h9-11,13-14,17-19,21-22,24H,6-8,12,15-16H2,1-5H3,(H,28,33)(H,29,31)(H,30,32)/t17-,18-,19-,21-,22-,24+/m0/s1
1.Nagai K, Doi T, Ohshiro T, Sunazuka T, Tomoda H, Takahashi T, Omura S.. (2008) Synthesis and biological evaluation of a focused library of beauveriolides., 18 (15):[PMID:18620856][10.1016/j.bmcl.2008.06.054]
2.Doi T, Muraoka T, Ohshiro T, Matsuda D, Yoshida M, Takahashi T, Omura S, Tomoda H.. (2012) Conformationally restricted analog and biotin-labeled probe based on beauveriolide III., 22 (1):[PMID:22079027][10.1016/j.bmcl.2011.10.045]
3. (2014) Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases,
4. (2015) Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease,
5.Kapojos MM, Abdjul DB, Yamazaki H, Ohshiro T, Rotinsulu H, Wewengkang DS, Sumilat DA, Tomoda H, Namikoshi M, Uchida R.. (2018) Callyspongiamides A and B, sterol O-acyltransferase inhibitors, from the Indonesian marine sponge Callyspongia sp., 28 (10):[PMID:29631961][10.1016/j.bmcl.2018.03.077]
6.Bhattacharjee P, Rutland N, Iyer MR.. (2022) Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential., 65 (24.0):[PMID:36473091][10.1021/acs.jmedchem.2c01265]